Study to Evaluate an Influenza Vaccine Candidate
NCT00321373
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
1220
Enrollment
INDUSTRY
Sponsor class
Conditions
Influenza
Interventions
BIOLOGICAL:
Candidate Influenza Vaccine GSK1247446A - 2 different formulations
BIOLOGICAL:
FluarixTM
Sponsor
GlaxoSmithKline